426 related articles for article (PubMed ID: 205163)
1. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
[TBL] [Abstract][Full Text] [Related]
3. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
[TBL] [Abstract][Full Text] [Related]
5. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
Kushwaha RS; Chait A; Hazzard WR
J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
[TBL] [Abstract][Full Text] [Related]
6. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia.
Durrington PN; Bolton CH; Hartog M
Clin Chim Acta; 1978 Jan; 82(1-2):151-60. PubMed ID: 201398
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.
Schaefer EJ; Blum CB; Levy RI; Jenkins LL; Alaupovic P; Foster DM; Brewer HB
N Engl J Med; 1978 Oct; 299(17):905-10. PubMed ID: 211412
[TBL] [Abstract][Full Text] [Related]
8. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
Jaillard J; Sezille G; Dewailly P; Fruchart JC
Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects.
Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Wang CS; Alaupovic P; Gregg RE; Brewer HB
Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
[TBL] [Abstract][Full Text] [Related]
12. Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations.
Olsson AG; Carlson LA
Acta Med Scand Suppl; 1975; 580():1-37. PubMed ID: 170799
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
[TBL] [Abstract][Full Text] [Related]
14. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
[TBL] [Abstract][Full Text] [Related]
15. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein composition in different types of hyperlipoproteinemia.
Carlson LA
Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
[TBL] [Abstract][Full Text] [Related]
17. Distribution and concentration of apolipoprotein E in high and low density lipoproteins.
Avogaro P; Bittolo Bon G; Cazzolato G; Pontoglio E; Kostner GM
Ric Clin Lab; 1983; 13(4):431-6. PubMed ID: 6658303
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
Breckenridge WC; Alaupovic P; Cox DW; Little JA
Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis?
Goldstein S; Duhamel G; Laudat MH; Berthelier M; Hervy C; Tete MJ; Broyer M
Nephron; 1984; 38(2):87-92. PubMed ID: 6433214
[TBL] [Abstract][Full Text] [Related]
20. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
Sandholzer C; Feussner G; Brunzell J; Utermann G
J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
